Efficacy and Safety of Ion Channel Modulators in Painful Diabetic Neuropathy.
Diabetes Obes MetabJul 8, 2026 (epub)
Dandan Li, Linqi Ouyang, Zhen Chen et al.
✦ AI-curated · Sources linked
In 30 seconds
This meta-analysis evaluated the efficacy and safety of ion channel modulators in treating painful diabetic neuropathy (PDN) across 36 randomized controlled trials involving 6611 participants. The study found that these modulators, particularly calcium channel blockers and sodium channel antagonists, significantly reduced pain and improved quality of life compared to placebo.
Key findings
- Ion channel modulators significantly reduced pain scores compared to placebo.
- Calcium channel blockers and sodium channel antagonists improved patient global impression of change (PGIC).
- 30% and 50% pain reduction was achieved more frequently with ion channel modulators.
- Adverse events were mild to moderate, with higher discontinuation rates for mirogabalin and oxcarbazepine.
Why it matters
Understanding the efficacy and safety of ion channel modulators can guide clinicians in managing painful diabetic neuropathy, a condition that significantly impacts patients' quality of life. Effective pain management strategies are essential for improving patient outcomes.